Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Merck announces FDA approval for GARDASIL against HPV-related anal cancer

Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] for the prevention of anal cancer caused by human papillomavirus (HPV) types 16 and 18 and for the prevention of anal intraepithelial neoplasia (AIN) grades 1, 2 and 3 (anal dysplasias and precancerous lesions) caused by HPV types 6, 11, 16 and 18, in males and females 9 through 26 years of age.

23 Dec 2010

New study reveals statin therapy linked to reduced postoperative mortality

Statin drugs were first introduced to lower blood cholesterol concentrations; however, research is now discovering other benefits. A new study from France, published in the January 2011 issue of Anesthesiology, is the first to analyze the impact of preoperative chronic statin therapy on postoperative adverse events in surgical patients. Findings from the study suggest that statin therapy is associated with reduced postoperative mortality.

23 Dec 2010

FDA approves Novartis' Amturnide for treatment of high blood pressure

Today Novartis announced that the US Food and Drug Administration (FDA) approved Amturnide (aliskiren, amlodipine and hydrochlorothiazide) tablets for the treatment of high blood pressure. Amturnide combines the only approved direct renin inhibitor worldwide, Tekturna (aliskiren), with the widely used calcium channel blocker amlodipine and the diuretic hydrochlorothiazide (HCTZ).

23 Dec 2010

New cough suppressant from cocoa

People suffering from persistent cough may soon have a remedy that is derived from cocoa. At present researchers are carrying out the final stages of clinical trials of a drug that contains theobromine, an ingredient found in chocolate and cocoa. The drug could be in the market in another two years.

22 Dec 2010

Walgreen first quarter sales increase 6.0% to record $17.3 billion

Walgreens announced record earnings and sales for the first quarter of fiscal year 2011.

22 Dec 2010

Seaside purchases additional $2.5M of NanoViricides' Series B Convertible Preferred Stock

NanoViricides, Inc., announced today that it had consummated a closing with Seaside 88, LP ("Seaside"), a Florida limited partnership, on Seaside's purchase of an additional $2.5M of the Company's Series B Convertible Preferred Stock. Seaside has financed several leading-edge bio-pharma companies, including Cytori Therapeutics, Inc., Generex Biotechnology Corporation, and NovaDel Pharma, Inc. among others.

22 Dec 2010

Vote For Kids Health calls for voting support to help win December Pepsi Refresh Project

Critically ill and disadvantaged children are counting on the generosity of strangers Thursday, December 23, 2010, asking for 100,000 votes to help win their grant ideas in the December Pepsi Refresh Project. Securing the thousands of votes needed to finish in winning spots is an uphill challenge for many organizations, but eight enterprising charities have joined forces to help each other into the winners circle.

22 Dec 2010

BioCryst commences BCX4208/allopurinol combination Phase 2b study in gout patients

BioCryst Pharmaceuticals, Inc. announced the initiation of a Phase 2b study of BCX4208 as add-on therapy in gout patients who have not responded to allopurinol therapy alone.

22 Dec 2010

New research sheds light on how neurons make connections with one another

Newly published research led by Professor Z. Josh Huang, Ph.D., of Cold Spring Harbor Laboratory sheds important new light on how neurons in the developing brain make connections with one another.

22 Dec 2010

Vitrolife receives FDA approval for RapitVit Blast and RapidWarm Blast vitrification products

Vitrolife has received approval from the U.S. Food and Drug Administration, FDA, the equivalent of the Swedish Medical Products Agency, for the products RapitVit™ Blast and RapidWarm™ Blast. So-called 510(k) clearance has been obtained for these products, which are used for so-called vitrification, the rapid freezing and thawing of blastocysts (embryos days 5-7 after fertilization). Vitrolife has since before approved products for vitrification of embryos in an earlier stage of the fertilization (embryos day 2-3 after fertilization).

22 Dec 2010

Echinacea only offers modest benefit in common cold: study

In a large clinical trial involving more than 700 adults and children researchers showed that the popular herbal remedy Echinacea can cut only half a day from a week long common cold. Echinacea has been marketed for a long time for the common cold. Echinacea, also known as purple coneflower has been shown to have benefits in some earlier studies while some show no benefits.

21 Dec 2010

Recent study finds racial and ethnic minority smokers of menthol cigarettes have lower quit rate

Menthol cigarettes may be harder to quit, particularly for some teens and African-Americans, who have the highest menthol cigarette use, according to a study by a team of researchers.

21 Dec 2010

Study: Chemotherapy can improve survival rate in older adolescents with leukemia

Research led by St. Jude Children-s Research Hospital investigators will likely impact how acute lymphoblastic leukemia is treated in young adults and shows older adolescent age does not dictate worse outcomes against the most common childhood cancer.

21 Dec 2010

Clue to the blues that come with the flu

Vanderbilt University researchers may have found a clue to the blues that can come with the flu - depression may be triggered by the same mechanisms that enable the immune system to respond to infection.

21 Dec 2010

Treatment with acid-suppressive drugs associated with increased risk of pneumonia

Using acid suppressive medications, such as proton pump inhibitors and histamine2 receptor antagonists, may increase the risk of developing pneumonia, states an article in CMAJ (Canadian Medical Association Journal).

21 Dec 2010

Echinacea may have minimal impact in relieving common cold

An over-the-counter herbal treatment believed to have medicinal benefits has minimal impact in relieving the common cold, according to research by the University of Wisconsin-Madison School of Medicine and Public Health.

21 Dec 2010

Exosomes derived from lymphoma, colorectal cancer patients circulated through Aethlon's Hemopurifier

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that it has demonstrated the ability to capture immunosuppressive exosomes derived from individuals with lymphoma and colorectal cancer.

20 Dec 2010

Participants in CMS, Premier healthcare alliance HQID VBP project raise quality by 18.3%

With value-based purchasing (VBP) now law under health reform, hospitals participating in the nation's largest hospital VBP demonstration are providing lessons learned that can help others save lives and better craft rules to govern the new program.

20 Dec 2010

AAPD pediatric oral health experts partner with text4baby to provide information to pregnant women, new moms

The American Academy of Pediatric Dentistry (AAPD), the recognized leader in children's oral health, announced today an outreach partnership with the text4baby program. The AAPD's leading pediatric oral health experts will work closely with text4baby in the dissemination of information to pregnant women and new moms about children's oral health care.

20 Dec 2010

SEEK announces new joint venture entity with Pernix Therapeutics for antitussive drug development

SEEK, a leading UK privately-owned drug-discovery group, is pleased to announce the establishment of a new joint venture entity with Pernix Therapeutics Holdings, an integrated specialty pharmaceutical company focused primarily on the United States pediatric market.

20 Dec 2010

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Merck announces FDA approval for GARDASIL against HPV-related anal cancer

New study reveals statin therapy linked to reduced postoperative mortality

FDA approves Novartis' Amturnide for treatment of high blood pressure

New cough suppressant from cocoa

Walgreen first quarter sales increase 6.0% to record $17.3 billion

Seaside purchases additional $2.5M of NanoViricides' Series B Convertible Preferred Stock

Vote For Kids Health calls for voting support to help win December Pepsi Refresh Project

BioCryst commences BCX4208/allopurinol combination Phase 2b study in gout patients

New research sheds light on how neurons make connections with one another

Vitrolife receives FDA approval for RapitVit Blast and RapidWarm Blast vitrification products

Echinacea only offers modest benefit in common cold: study

Recent study finds racial and ethnic minority smokers of menthol cigarettes have lower quit rate

Study: Chemotherapy can improve survival rate in older adolescents with leukemia

Clue to the blues that come with the flu

Treatment with acid-suppressive drugs associated with increased risk of pneumonia

Echinacea may have minimal impact in relieving common cold

Exosomes derived from lymphoma, colorectal cancer patients circulated through Aethlon's Hemopurifier

Participants in CMS, Premier healthcare alliance HQID VBP project raise quality by 18.3%

AAPD pediatric oral health experts partner with text4baby to provide information to pregnant women, new moms

SEEK announces new joint venture entity with Pernix Therapeutics for antitussive drug development

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in